Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
Clinical trial NCT00316563 · COMPLETED
Trial details
- NCT number
- NCT00316563
- Sponsor
- Alberta Health services
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.